Amitriptyline
- 1 lab in 1 country
- Humans2
Outcomes
1MeReCAE index
upin silico1
1 study
MeReCAE index
upin silico1
Amitriptyline increases MeReCAE index in silico.
“A more important shift toward higher MeReCAE values was observed when amitriptyline and asenapine were added to the drug regimen of patients.”
In silicovirtual addition to patient drug regimens
GSA 2024 abstract31 Dec 2024
Associations
1Alzheimer's disease and related dementia
downin humans1
1 study
Alzheimer's disease and related dementia
downin humans1
Amitriptyline lowers the risk of Alzheimer's disease and related dementia in humans (IRR 0.8; 95% CI 0.8–0.9).
“Some protective phenothiazines in our dataset included amitriptyline (IRR 0.8; 95%CI 0.8‐0.9)”
Humans
AAIC 2025 abstract23 Dec 2025
Latest
1 in 12 monthsAAIC 2025 Abstract
Experimental and real‐world evidence supporting the repurposing of drugs targeting proteotoxicity and inflammation to treat Alzheimer's disease
Cross-sectional study in peopleAlzheimer's disease
Scientific Reports
Amitriptyline increases food intake via prdx-2 without altering other physiological parameters in C. elegans under a modified bacterial diet
Experiments in model organismsInterventions
GSA 2024 Abstract
A NEW MEDICATION-RELATED CUMULATIVE ANTICHOLINERGIC EXPOSURE INDEX EVALUATING RISK OF COGNITIVE IMPAIRMENT
Study of 12,383 peopleCognitive impairment